Amgen plunges 11%, hits lowest level in a year



Amgen Inc. shares dropped more than 11% on Tuesday, marking their lowest point since November 2023. The decline followed disappointing Phase 2 trial results for its weight-loss drug, MariTide, which s…
About the author:

Get involved!

Fai trading in gruppo!
L'unica Academy di trading completamente gratuita per gli utenti FpMarkets

Comments

Ancora nessun commento